These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6340562)

  • 1. Double-blind study of papaverine hydrochloride on the efficacy in the treatment of intermittent claudication.
    Seino Y; Rose HB; Kanazawa M; Vyden JK; Wall FJ
    Angiology; 1983 Apr; 34(4):257-65. PubMed ID: 6340562
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of ethaverine hydrochloride on the walking tolerance of patients with intermittent claudication.
    Trainor FS; Phillips RE; Michie DD; Zellner SR; Hogan L; Chubb JM
    Angiology; 1986 May; 37(5):343-51. PubMed ID: 3521401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized placebo-controlled, double-blind trial of ketanserin in treatment of intermittent claudication.
    Walden R; Bass A; Rabi I; Adar R
    J Cardiovasc Surg (Torino); 1991; 32(6):737-40. PubMed ID: 1752890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebo-controlled trial of ketanserin in the treatment of intermittent claudication.
    Cameron HA; Waller PC; Ramsay LE
    Angiology; 1987 Jul; 38(7):549-55. PubMed ID: 3304029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of naftidrofuryl in patients with intermittent claudication.
    Karnik R; Valentin A; Stöllberger C; Slany J
    Angiology; 1988 Mar; 39(3 Pt 1):234-40. PubMed ID: 3281516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further evaluation of papaverine for peripheral vascular ischemia.
    Stern FH
    J Am Geriatr Soc; 1967 Apr; 15(4):386-93. PubMed ID: 5335635
    [No Abstract]   [Full Text] [Related]  

  • 7. A double-blind placebo-controlled study of Hexopal in the treatment of intermittent claudication.
    O'Hara J
    J Int Med Res; 1985; 13(6):322-7. PubMed ID: 3908186
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intermittent intra-arterial infusion treatment of severe intermittent claudication--results of a prospective double-blind study of prostaglandin E1 versus energy-rich phosphates].
    Creutzig A; Caspary L; Radeke U; Specht S; Alexander K
    Vasa Suppl; 1988; 23():133-5. PubMed ID: 3061036
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intermittent intra-arterial infusion treatment of severe intermittent claudication. Results of a prospective double-blind study: prostaglandin El versus energy-rich phosphates].
    Creutzig A; Caspary L; Radeke U; Specht S; Ranke C; Alexander K
    Med Klin (Munich); 1988 Jun; 83(13-14):434-8. PubMed ID: 3062344
    [No Abstract]   [Full Text] [Related]  

  • 10. Ketanserin in intermittent claudication. A double-blind placebo-controlled study.
    Clement DL; Duprez D; Van Wassenhove A; Brusselmans F
    Int Angiol; 1989; 8(2):92-6. PubMed ID: 2681451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intermittent claudication. Attempt at an objective vue of the disease and the possible treatment results with Sibelium].
    Loots W; Dom J; Hörig C
    Med Welt; 1980 Feb; 31(5):189-92. PubMed ID: 7366398
    [No Abstract]   [Full Text] [Related]  

  • 12. β-Blockers in patients with intermittent claudication and arterial hypertension: results from the nebivolol or metoprolol in arterial occlusive disease trial.
    Espinola-Klein C; Weisser G; Jagodzinski A; Savvidis S; Warnholtz A; Ostad MA; Gori T; Munzel T
    Hypertension; 2011 Aug; 58(2):148-54. PubMed ID: 21646599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and microcirculatory effects of transcutaneous CO2 therapy in intermittent claudication. Randomized double-blind clinical trial with a parallel design.
    Fabry R; Monnet P; Schmidt J; Lusson JR; Carpentier PH; Baguet JC; Dubray C
    Vasa; 2009 Aug; 38(3):213-24. PubMed ID: 19736632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leg cramps in geriatric diabetics with peripheral vascular ischemia: treatment.
    Stern FH
    J Am Geriatr Soc; 1966 Jun; 14(6):609-16. PubMed ID: 5327768
    [No Abstract]   [Full Text] [Related]  

  • 15. Ketanserin in intermittent claudication: effect on walking distance, blood pressure, and cardiovascular complications.
    Thulesius O; Lundvall J; Kroese A; Stranden E; Hallböök T; Brunes L; Gjöres JE; Akesson H; Einarsson E; Ohlin P
    J Cardiovasc Pharmacol; 1987 Jun; 9(6):728-33. PubMed ID: 2442541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The therapeutic efficacy of inositol nicotinate (Hexopal) in intermittent claudication: a controlled trial.
    O'Hara J; Jolly PN; Nicol CG
    Br J Clin Pract; 1988 Sep; 42(9):377-83. PubMed ID: 3075929
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intermittent claudication treated with pentoxifylline. A controlled trial].
    Skovborg F; Bonde-Petersen F; Bloch I; Christensen E
    Ugeskr Laeger; 1983 Nov; 145(47):3649-52. PubMed ID: 6362159
    [No Abstract]   [Full Text] [Related]  

  • 18. Intermittent claudication: Suloctidil v.s. placebo treatment.
    Holm J; Lindblad L; Scherstén T; Suurkula M
    Vasa; 1984; 13(2):175-8. PubMed ID: 6331019
    [No Abstract]   [Full Text] [Related]  

  • 19. The effectiveness of isoxsuprine in patients with intermittent claudication.
    Skotnicki SH; van Gaal G; Wijn PF
    Angiology; 1984 Nov; 35(11):685-93. PubMed ID: 6388424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of intermittent claudication with inositol nicotinate.
    Head A
    Practitioner; 1986 Jan; 230(1411):49-54. PubMed ID: 3513149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.